A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes

PHASE2SuspendedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

May 31, 2016

Conditions

Diabetes Mellitus

Interventions

DRUG

BIOD-531

DRUG

Humalog® Mix 75/25

Trial Locations (7)

Diabetes and Endocrinology Consultants, Morehead City

Endocrine Research Solutions, Roswell

Meridien Research, Bradenton

Cedar Crosse Research Center, Chicago

Springfield Diabetes and Endocrine Center, Springfield

Clinical Trials of Texas, San Antonio

Ranier Clinical Research Center, Renton